Comments on: PPHM’s Bavituximab in Early Clinical Trials http://www.hammerstockblog.com/pphms-bavituximab-in-early-clinical-trials/ Biotech stock reviews Sat, 19 May 2012 10:35:16 +0000 http://wordpress.org/?v=2.3.1 By: Ohad Hammer http://www.hammerstockblog.com/pphms-bavituximab-in-early-clinical-trials/#comment-133 Ohad Hammer Fri, 18 Apr 2008 21:42:03 +0000 http://www.hammerstockblog.com/pphms-bavituximab-in-early-clinical-trials/#comment-133 The company expects to have preliminary data from the Georgia phase II trial of bavituximab+docetaxel this summer, after the first set of 15 patients are enrolled. Hopefully, by that time there will be a sufficient number of assessments to decide whether the trial will be expanded to 31 patients. Unless response rate is abnormally high, this data does not seem to be very meaningful. By next summer we should get a better idea with respect to bavi's activity, as there would be mature data for over 100 patients from 3 different trials. The company expects to have preliminary data from the Georgia phase II trial of bavituximab+docetaxel this summer, after the first set of 15 patients are enrolled. Hopefully, by that time there will be a sufficient number of assessments to decide whether the trial will be expanded to 31 patients.
Unless response rate is abnormally high, this data does not seem to be very meaningful.

By next summer we should get a better idea with respect to bavi’s activity, as there would be mature data for over 100 patients from 3 different trials.

]]> By: Ralph Meissner http://www.hammerstockblog.com/pphms-bavituximab-in-early-clinical-trials/#comment-132 Ralph Meissner Thu, 17 Apr 2008 17:13:36 +0000 http://www.hammerstockblog.com/pphms-bavituximab-in-early-clinical-trials/#comment-132 Any other news on phase II trials currently underway? When should we expect results from current phase II trials? Any other news on phase II trials currently underway? When should we expect results from current phase II trials?

]]>